Share this article and save a life!
A physician sits in a reading room in Cleveland. Before she touches a single chart, an AI agent has already triaged her queue, flagged a coronary risk from an incidental scan, and routed three patients to telemedicine. That is not a pilot. That is production in 2026. 🔥
This week reminded me why I do what I do. Healthcare’s biggest, most stubborn problems are finally attracting real capital at real scale.
Every verified deal from the week of July 21, 2026:
Candid Health: $120M Series D, led by Sixth Street Growth. Automated medical billing and reimbursement. Tripled valuation since Series C. Over 200 healthcare orgs.
Pearl Health: $110M. AI platform helping primary care physicians deliver better outcomes at lower cost for Medicare patients.
Bunkerhill Health: $25M Series B, led by Khosla Ventures. Agentic AI for health systems. 20+ agents in production at Cleveland Clinic, Mayo Clinic, Intermountain.
TytoCare: $25M+ growth round, led by Insight Partners. Remote physical examination technology, repositioning as AI-first clinical enablement.
Plazza: $15M Series A, co-led by Accel, Elevation, Nexus. Pharmacy-first quick-commerce delivering medicines in 15 to 30 minutes.
The pattern matters more than any single deal.
Three of these five are attacking operational and financial infrastructure, not clinical outcomes. Revenue cycle. Value-based reimbursement. Agentic workflow automation. That is where the bleeding is.
💡 Two late-stage rounds over $100M alongside a Series B and a Series A. Investors are writing checks to companies with deployments, not decks.
Candid Health tripling its valuation while building revenue cycle software should stop every founder chasing flashy clinical AI. The boring stuff is getting funded. The billing infrastructure. The credentialing automation. The agentic workflow a radiologist never sees but a CFO tracks on a dashboard.
If you are raising, understand what stage of the market you are in. Investors this week deployed the most capital at growth and late stage. They are following revenue. Your pitch needs proof of workflow impact, not just clinical validity.
Healthcare’s hardest problems are not waiting for permission anymore.
👉 Follow Jonathan Govette, CEO of Oatmeal Health, for daily healthcare insights on LinkedIn. Deeper dives in The Oatmeal Bite on Substack: https://news.oatmealhealth.com
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
